Lecanemab: appropriate use recommendations: a commentary from a European perspective
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2023
|
| In: |
The journal of prevention of Alzheimer's disease
Year: 2023, Jahrgang: 10, Heft: 3, Pages: 357-358 |
| ISSN: | 2426-0266 |
| DOI: | 10.14283/jpad.2023.44 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.14283/jpad.2023.44 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.14283/jpad.2023.44 
|
| Verfasserangaben: | Lutz Frölich, F. Jessen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1898741255 | ||
| 003 | DE-627 | ||
| 005 | 20241205162810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240815s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14283/jpad.2023.44 |2 doi | |
| 035 | |a (DE-627)1898741255 | ||
| 035 | |a (DE-599)KXP1898741255 | ||
| 035 | |a (OCoLC)1475307593 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 11 |2 sdnb | ||
| 100 | 1 | |a Frölich, Lutz |d 1956- |e VerfasserIn |0 (DE-588)1028327099 |0 (DE-627)730567516 |0 (DE-576)375813160 |4 aut | |
| 245 | 1 | 0 | |a Lecanemab: appropriate use recommendations |b a commentary from a European perspective |c Lutz Frölich, F. Jessen |
| 264 | 1 | |c September 2023 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 8. April 2023 | ||
| 500 | |a Gesehen am 15.08.2024 | ||
| 700 | 1 | |a Jessen, Frank |d 1967- |e VerfasserIn |0 (DE-588)12077447X |0 (DE-627)080880762 |0 (DE-576)292379285 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of prevention of Alzheimer's disease |d [Paris] : Elsevier Masson SAS, 2014 |g 10(2023), 3, Seite 357-358 |h Online-Ressource |w (DE-627)795124716 |w (DE-600)2782183-3 |w (DE-576)411990772 |x 2426-0266 |7 nnas |a Lecanemab: appropriate use recommendations a commentary from a European perspective |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:3 |g pages:357-358 |g extent:2 |a Lecanemab: appropriate use recommendations a commentary from a European perspective |
| 856 | 4 | 0 | |u https://doi.org/10.14283/jpad.2023.44 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.14283/jpad.2023.44 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240815 | ||
| 993 | |a Editorial | ||
| 994 | |a 2023 | ||
| 998 | |g 1028327099 |a Frölich, Lutz |m 1028327099:Frölich, Lutz |d 60000 |e 60000PF1028327099 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1898741255 |e 4566296555 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"family":"Frölich","display":"Frölich, Lutz","role":"aut","given":"Lutz"},{"family":"Jessen","display":"Jessen, Frank","given":"Frank","role":"aut"}],"recId":"1898741255","relHost":[{"title":[{"title_sort":"journal of prevention of Alzheimer's disease","subtitle":"JPAD","title":"The journal of prevention of Alzheimer's disease"}],"pubHistory":["1.2014 -"],"origin":[{"dateIssuedKey":"2025","publisher":"Elsevier Masson SAS ; SERDI ; Springer International Publishing","dateIssuedDisp":"2025-","publisherPlace":"[Paris] ; Toulouse ; Cham"}],"note":["Gesehen am 04.02.25"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Lecanemab: appropriate use recommendations a commentary from a European perspectiveThe journal of prevention of Alzheimer's disease","recId":"795124716","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Clinical Trials on Alzheimer's Disease (CTAD) ; International Association of Gerontology and Geriatrics (IAGG)"]},"id":{"zdb":["2782183-3"],"issn":["2426-0266"],"eki":["795124716"]},"language":["eng"],"part":{"volume":"10","extent":"2","pages":"357-358","year":"2023","issue":"3","text":"10(2023), 3, Seite 357-358"}}],"physDesc":[{"extent":"2 S."}],"name":{"displayForm":["Lutz Frölich, F. Jessen"]},"id":{"doi":["10.14283/jpad.2023.44"],"eki":["1898741255"]},"title":[{"title":"Lecanemab: appropriate use recommendations","title_sort":"Lecanemab: appropriate use recommendations","subtitle":"a commentary from a European perspective"}],"origin":[{"dateIssuedDisp":"September 2023","dateIssuedKey":"2023"}],"note":["Online veröffentlicht: 8. April 2023","Gesehen am 15.08.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a FROELICHLULECANEMABA2023 | ||